site update final programme

8
update I nternaonal Symposium on Endovascular Therapeucs Aula Magna, School of Medicine. University of Barcelona BARCELONA, Spain · May 9 th , 2014 BEYOND THE EVIDENCE powered by www.sitesymposium.org Final Program Organising Commiee Chairman V. Riambau Program Directors J. Fernández-Noya, G. Mestres and N. Mosquera

Upload: salutaria

Post on 03-Jun-2015

105 views

Category:

Health & Medicine


2 download

TRANSCRIPT

Page 1: Site update final programme

updateInternational Symposium onEndovascular Therapeutics

Aula Magna, School of Medicine. University of BarcelonaBARCELONA, Spain · May 9th, 2014

BEYOND THE EVIDENCE

powered by

www.sitesymposium.org

Final Program

Organising CommitteeChairmanV. Riambau

Program DirectorsJ. Fernández-Noya, G. Mestres and N. Mosquera

Page 2: Site update final programme

update BEYOND THE EVIDENCE

International Symposium on Endovascular Therapeutics

2

Faculty ListAlburquerque Castro, Joao4PortugalBarroso, Joan Manel4SpainBiamino, Giancarlo4ItalyBlanes, Ignacio4SpainBöckler, Dittmar4GermanyCheshire, Nick4UKClough, Rachael4UKDeloose, Koen4BelgiumFernández-Noya, Jorge4SpainFerri, Michelangelo4ItalyGaines, Peter4UKGómez-Manzano, Mª Teresa4SpainGómez-Palonés, Francisco4SpainHardman, John4UK

Loftus, Ian4UKMestres, Gaspar4SpainMiralles, Manuel4SpainMoll, Frans4The NetherlandsMosquera, Nilo4SpainPalmero, Julio4SpainPuras, Enrique4SpainRabbia, Claudio4ItalyRiambau, Vicente4SpainRousseau, Herve4FranceTrilla, Antoni4SpainVarcoe, Ramon4AustraliaVaquero, Fernando4SpainVeith, Frank4USA

Dear participant,SITEupdate is a new fresh formula for a useful expert event. In only one day, Faculty and an international advanced audience will review the unmet needs concerning two particular Focuses: Aorta repair and lower limb revascularization. The main objective is to identify current limitations and propose future directions.It is a new initiative with a different format than we usually have in conventional meetings and congresses. There are no classical presentations, except for clinical cases, unsolved or unsuitable cases, to be discussed with the selected expert audience in order to discover unmet needs in endovascular therapies. Committed Medical Device Companies are invited to share their pipelines and new concepts during the CONFIDENTIAL SESSIONS.All the participants are experts on endovascular procedures, bioengineering, industry management, technological evaluation, and health management administration. All of you, panellists and delegates should interact during the discussion periods. A real brainstorming is expected following a clear script and driven by two moderators in a real academic atmosphere. All the sessions, except for the Confidential ones, will be recorded and uploaded on www.endovascular.tv. A streaming platform and free wi-fi connection are provided.We hope you enjoy these interactive sessions and collaborate to develop new ideas to improve endovascular therapies.Welcome and thank you for your collaboration

V. RiambauSITE Chairman

Page 3: Site update final programme

update BEYOND THE EVIDENCE

International Symposium on Endovascular Therapeutics

May 8th, 2014

21:00 Welcome Dinner 4 Restaurante El Principal (Provença 286-288) INVITED LECTuRE Vegetal endotherapy: using vessels to control pest and diseased trees J.M. Barroso

May 9th, 2014

07:30 - 07:55 Registration

07:55 - 08:00 Welcome and Introduction

08:00 - 13:50 FOCus 1: uNsOLVED PROBLEMs ON AORTIC REPAIR

08:00 - 09:30 sEssION 1 Current limitations on thoracic endografting. Ascending, arch and thoraco-abdominal fates Moderators4 V. Riambau and F. Veith Panellists4 P. Gómez-Palonés, H. Rousseau, D. Böckler, R. Clough and N. Cheshire

09:30 - 11:00 sEssION 2 Current unmet needs on abdominal aorta endografting. The Infra justa and para-renal aneurysm fates Moderators4 N. Mosquera and F. Veith Panellists4 R. Varcoe, J. Hardman, I. Loftus, M. Miralles and F. Moll

11:00 - 11:20 Break

Final Program

FOCu

s 1

3

Page 4: Site update final programme

update BEYOND THE EVIDENCE

International Symposium on Endovascular Therapeutics

4

11:20 - 12:50 sEssION 3. THE CONFIDENTIAL sEssION Taking a look into the pipeline; new devices and innovative concepts from the industry Moderators4G. Mestres and J. Fernández-Noya

FOCu

s 1

Bolton Medical The next generation thoracic stent-graft: Relay PRO Roger Ferrer

Cook Medical Off the shelf endovascular treatment John Mogensen

Cordis Cordis present and future in aorta treatment stefaan Van Der Meulen

Endologix Nellix: Is EVAs the future of EVAR? Ian Loftus

Jotec Will active fixation change aortic endograft indications and features? Thierry Richards

Lombard Medical Development of a Lombard Medical Thoracic stent graft based on the core Aorfix technology to address unmet clinical needs Peter Phillips

Medtronic Medtronic’s next generation innovations brief summary Ido Many

Trivascular/Lexel science of seal Paolo Pece

W.L. Gore A continuous stream of innovative solutions and distinct technology capabilities to address aortic clinical challenges Benedeta Bosi

12:50 - 13:50 sEssION 4 unsolved or unsuitable cases for discussion Moderators4N. Mosquera and V. Riambau Panellists4 J. Alburquerque-Castro and J. Palmero Presenters4 J. Alburquerque-Castro, F. Veith, I. Loftus, H. Rousseau and J. Palmero

May 9th, 2014

Page 5: Site update final programme

update BEYOND THE EVIDENCE

International Symposium on Endovascular Therapeutics

5

13:50 - 15:05 sEssION 5 WORKING LuNCH WITH FACuLTy4School of Medicine

Critical requirements for technical innovation in Medicine Invited Plenary Lecture, 30 minutes A. Trilla President of the Executive Council of the Information, Evaluation and Health Quality Agency (Agència d’Informació, Avaluació i Qualitat en Salut de Catalunya-AIAQS)

M.T. Gómez-Manzano System, Product and Service Certification, SGS ICS Ibérica, S.A.

15:05 - 15:20 FIRST PRIzE “Forum Champions League” Hosted by M.A. serrano

Supported by 4

May 9th, 2014

Page 6: Site update final programme

update BEYOND THE EVIDENCE

International Symposium on Endovascular Therapeutics

15:20 - 19:00 FOCus 2: LOWER LIMB THERAPy: uNsOLVED PROBLEMs

15:20 - 16:50 sEssION 6 unsolved issues in lower limb endo-revascularization: From the lacking evidence up to the durability concerns Moderators4J. Fernández-Noya and G. Mestres Panellists4 R. Varcoe, E. Puras, C. Rabbia, G. Biamino, K. Deloose and P. Gaines

16:50 - 17:20 Break

17:20 - 18:00 sEssION 7. THE CONFIDENTIAL sEssION Taking a look into the pipeline; new therapies are coming up Moderators4G. Mestres and J. Fernández-Noya

Bard A closer look at the future of peripheral interventions Nicolas Jaramillo

Boston scientific Boston scientific: What’s in the pipeline? Juan Diáz-Cartelle

Covidien Healthcare economic impact on Innovation Ann Hickey

W.L. Gore Delivering performance - Today and tomorrow. Be among the first to know about peripheral products in our development pipeline Francesca Albertini

18:00 - 19:00 sEssION 8 uncommon tricks and tips. Clinical cases Moderators4J. Fernández-Noya and G. Mestres Panellists4 F. Vaquero, G. Biamino and I. Blanes Presenters4 M. Miralles, G. Biamino, C. Rabbia and M. Ferri

19:00 Conclusions and Wrapping up

FOCu

s 2

May 9th, 2014

6

Page 7: Site update final programme

update BEYOND THE EVIDENCE

International Symposium on Endovascular Therapeutics

Venue Medical School - University of Barcelona Aula Magna · Casanova 143 08036 Barcelona, Spain

Date May 9th, 2014 Focus 1408:00 - 13:30 Focus 2415:00 - 19:00

General Information

Registration Fees*Limited number of participants up to 120

Focus 1 + 2 Focus 1 Focus 2

300 € 200 € 200 €

www.sitesymposium.org

Av. Diagonal, 416, 3ª 1º • 08037 Barcelona, SpainTel. +34 935 052 503 • Fax +34 934 883 [email protected]

General secretariat

* The dinner on 8th May and lunch on 9th are included in all registration bands

Symposium compliant with the “Eucomed Code of Ethical Business Practice”

• Status update on two main endovascular focuses in one working day• Review of major clinical limitations and unmet needs (diagnosis, navigation and

procedures)• What is coming up from the industry pipeline?• Identify future directions• unsolved clinical cases and potential solutions• Direct interaction with the expert audience and industry leaders• Official Language: English. Simultaneous translation (English-Spanish) and

Audience Response System will be available

Format

Page 8: Site update final programme

Sponsors

www.sitesymposium.org